Eg. Stuchi-perez et al., Evaluation of the tubular and interstitial functions of the testis in 46,XY patients with ambiguous genitalia, J PED END M, 13(6), 2000, pp. 605-612
Investigation of the origin of sexual ambiguity is complex. Although testic
ular function has traditionally been assessed only by examining the steroid
ogenic capacity of Leydig cells and spermatogenesis, it has recently been s
hown that the measurement of serum anti-Mullerian hormone (AMH) as a marker
of Sertoli cell function may also help clinicians. The aim of this study w
as to evaluate both Leydig and Sertoli cell functions in 46,XY patients wit
h intersex states in order to establish biochemical patterns that would hel
p to reach an etiologic diagnosis. We measured serum androgens, AMH and gon
adotropins in 24 patients with sexual ambiguity and XY karyotype: 8 with go
nadal dysgenesis (GD), 3 with 3 beta-hydroxy-steroid dehydrogenase deficien
cy (3 beta HSD), 5 with androgen insensitivity syndrome (AIS), 4 with 5 alp
ha-reductase 2 (SRD5A2) deficiency, and 4 were of unknown origin or idiopat
hic, Our results showed that while testosterone was low and gonadotropins e
levated in patients with either GD or 3 beta HSD, AMH was low in the former
and high in the latter. Serum AMH and gonadotropins were normal or high in
patients with 3 beta HSD or AIS, but these could be distinguished by testo
sterone levels. Serum testosterone and gonadotropins were normal or high in
AIS and SRD5A2 deficiency patients; however, while AMH was elevated in AIS
, it was not the case in SRD5A2 deficiency patients, indicating that testos
terone is sufficient to inhibit AMH within the testis. In idiopathic cases
gonadotropins and testosterone were normal, and AMH was normal or low. We c
onclude that the combined measurement of androgens, AMH and gonadotropins h
elps to establish the diagnosis in intersex patients.